ENTRY       D01155                      Drug
NAME        Gemcitabine hydrochloride (JAN/USP);
            Gemzar (TN)
PRODUCT     GEMCITABINE (Accord Healthcare)
            GEMCITABINE (BluePoint Laboratories)
            GEMCITABINE (Hospira)
            GEMCITABINE (Hospira)
  GENERIC   GEMCITABINE (Armas Pharmaceuticals)
            GEMCITABINE (Armas Pharmaceuticals)
            GEMCITABINE (Armas Pharmaceuticals)
            GEMCITABINE (Athenex Pharmaceutical Division)
            GEMCITABINE (Dr. Reddy's Laboratories Limited)
            GEMCITABINE (Fresenius Kabi USA)
            GEMCITABINE (Fresenius Kabi USA)
            GEMCITABINE (Fresenius Kabi USA)
            GEMCITABINE (Hikma Pharmaceuticals USA)
            GEMCITABINE (Hospira)
            GEMCITABINE (Hospira)
            GEMCITABINE (Ingenus Pharmaceuticals)
            GEMCITABINE (Meitheal Pharmaceuticals)
            GEMCITABINE (Meitheal Pharmaceuticals)
            GEMCITABINE (Mylan Institutional LLC)
            GEMCITABINE (NorthStar Rx LLC)
            GEMCITABINE (Sagent Pharmaceuticals)
            GEMCITABINE HYDROCHLORIDE (Accord Healthcare)
            GEMCITABINE HYDROCHLORIDE (Gland Pharma Limited)
FORMULA     C9H11F2N3O4. HCl
EXACT_MASS  299.0484
MOL_WEIGHT  299.6591
CLASS       Antineoplastic
             DG02018  Antimetabolite
              DG01958  Nucleic acid derivative, antineoplastic
               DG01439  Arabinofuranosyl type antineoplastic
REMARK      Therapeutic category: 4224
            ATC code: L01BC05
            Chemical structure group: DG00688
            Product (DG00688): D01155<JP/US>
EFFICACY    Antineoplastic, Antimetabolite
  DISEASE   Ovarian cancer [DS:H00027]
            Breast cancer [DS:H00031]
            Non-small cell lung cancer [DS:H00014]
            Pancreatic cancer [DS:H00019]
TARGET      RRM1 [HSA:6240] [KO:K10807]
  PATHWAY   hsa00230(6240)  Purine metabolism
            hsa00240(6240)  Pyrimidine metabolism
INTERACTION  
STR_MAP     map07041  Antineoplastics - antimetabolic agents
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L01 ANTINEOPLASTIC AGENTS
               L01B ANTIMETABOLITES
                L01BC Pyrimidine analogues
                 L01BC05 Gemcitabine
                  D01155  Gemcitabine hydrochloride (JAN/USP) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antineoplastics
              Antimetabolites
               Gemcitabine
                D01155  Gemcitabine hydrochloride (JAN/USP)
            Therapeutic category of drugs in Japan [BR:br08301]
             4  Agents affecting cellular function
              42  Antineoplastics
               422  Antimetabolites
                4224  Cytosines
                 D01155  Gemcitabine hydrochloride (JAN/USP)
            Drug groups [BR:br08330]
             Antineoplastic
              DG02018  Antimetabolite
               DG01958  Nucleic acid derivative, antineoplastic
                DG01439  Arabinofuranosyl type antineoplastic
                 DG00688  Gemcitabine
                  D01155  Gemcitabine hydrochloride
            Drug classes [BR:br08332]
             Antineoplastic
              DG02018  Antimetabolite
               D01155  Gemcitabine hydrochloride
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Oxidoreductases (EC1)
               Ribonucleoside-diphosphate reductase
                RRM1
                 D01155  Gemcitabine hydrochloride (JAN/USP) &lt;JP/US&gt;
            Drug groups [BR:br08330]
             Antineoplastic
              DG02018  Antimetabolite
               DG01958  Nucleic acid derivative, antineoplastic
                DG01439  Arabinofuranosyl type antineoplastic
                 DG00688  Gemcitabine
DBLINKS     CAS: 122111-03-9
            PubChem: 7848218
            ChEBI: 31647
            LigandBox: D01155
            NIKKAJI: J1.894.035C
ATOM        19
            1   X   Cl   23.2764  -19.8780
            2   C1y C    17.7120  -17.4316
            3   N4y N    19.0399  -16.3826
            4   C1z C    17.3620  -18.7617
            5   O2x O    16.5919  -16.5915
            6   C8y C    20.2923  -17.0271
            7   C8x C    19.0366  -15.0038
            8   C1y C    15.8918  -18.7617
            9   X   F    17.3620  -20.1618
            10  X   F    18.6221  -18.7617
            11  C1y C    15.4718  -17.4316
            12  N5x N    21.4481  -16.2155
            13  O5x O    20.2882  -18.2891
            14  C8x C    20.2624  -14.1922
            15  O1a O    15.0518  -19.8118
            16  C1b C    14.2817  -17.0116
            17  C8y C    21.4448  -14.8367
            18  O1a O    13.2316  -18.0616
            19  N1a N    22.6122  -14.0638
BOND        19
            1     2   3 1 #Up
            2     2   4 1
            3     2   5 1
            4     3   6 1
            5     3   7 1
            6     4   8 1
            7     4   9 1
            8     4  10 1
            9     5  11 1
            10    6  12 1
            11    6  13 2
            12    7  14 2
            13    8  15 1 #Down
            14   11  16 1 #Up
            15   12  17 2
            16   16  18 1
            17   17  19 1
            18    8  11 1
            19   14  17 1
///
